Company intelligence / Profile preview

Raypal Biomedical Co., Ltd.

Taipei, Taipei City, Taiwantrpma.org.tw ↗

Ownership: Private
Development stage: Phase 1

Overview

Raypal Biomedical has completed a Phase I/II clinical trial evaluating the safety and efficacy of cytokine-induced killer (CIK) treatment for advanced hepatocellular carcinoma, with additional autologous CIK programs approved for late-stage cancer patients at multiple hospitals in Taiwan. The company is also developing stem-cell derived exosome products that have received international cosmetic ingredient certification, as well as patented cartilage regeneration technologies. Their GTP/GMP-compliant facilities support ongoing R&D and manufacturing efforts[6].

Therapeutic areas: OncologyDermatologyRheumatology
Modalities: Immune cell therapy (e.g. cytokine-induced killer cells)Stem cell therapyExosome-based productsRegenerative medicine (cartilage cell sheets)
Industry: Biotech

Drug pipeline

3 assets

DC-CIK cells

Phase 1/2

Indications: Advanced hepatocellular carcinoma, Stage IV solid tumors

2 more assets in the full pipeline.

Request access →

Partnerships

Kaohsiung Medical University Chung-Ho Memorial Hospital – joint GTP laboratory and clinical collaboration on cellular therapies[4][6]Multiple hospital collaborations in Taiwan including Cheng Ching Hospital, Tungs’ Taichung Metro Harbor Hospital, Chi Mei Hospital[6]

Beyond the preview

Go deeper on Raypal Biomedical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raypal Biomedical Co., Ltd..

Explore the full profile